In the News

Maryland Matters: Maryland board moves to set ceiling on what state will pay for Jardiance, Farxiga

Maryland MattersDanielle J. BrownNovember 17, 2025 EXCERPT: “The Maryland Prescription Drug

In the News

Maryland Matters: County leaders urge prescription drug board to set ‘upper payment limits’

September 30, 2025Maryland MattersDanielle Brown Excerpt: “County leaders urged the

News

Media Release: Local leaders line up to praise Prescription Drug Affordability Board, Urge it to set upper payment limits for two medications

New ad campaign features local leaders thanking the PDAB for its efforts to control spiraling drug

In the News

Baltimore Sun: Maryland prescription drug cost study finds 2 diabetes medicines have ‘affordability challenges’

July 29, 2025Baltimore SunChevall Pryce Excerpt: “During Monday’s meeting, the board took a

In the News

Maryland Matters: State board determines two Type 2 diabetes drugs may be unaffordable

Jardiance, Farxiga are the first drugs to complete PDAB’s cost review process, clearing the way

News

Statement: Maryland Health Care for All! Coalition Statement About Actions Today By the Prescription Drug Affordability Board

July 28, 2025 For Immediate Release Vincent DeMarco, president of the Maryland Health Care for All!

In the News

Inside Health Policy:Maryland PDAB Votes Farxiga, Jardiance As Unaffordable

July 28, 2025Inside Health PolicyLuke Zarzecki Excerpt: “The Maryland Prescription Drug